Larvol Delta - BTK-Is-the-Target-That-Keeps-on-Giving-A-Review-of-BTKDegrader-Drug-Development-Clinical-Data-and-Future-Directions-in-CLL

zelebrudomide (NX-2127) - Nurix Therap

NX-5948 - Nurix Therap

AC676 - Accutar Biotech

BGB-16673 - BeiGene

http://www.ncbi.nlm.nih.gov/pubmed/39941922

Jamie Brennan; Katharine L Lewis; Ross T Salvaris

Feb 13, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next